cimicoxib has been researched along with phosphoramidic acid in 1 studies
| Studies (cimicoxib) | Trials (cimicoxib) | Recent Studies (post-2010) (cimicoxib) | Studies (phosphoramidic acid) | Trials (phosphoramidic acid) | Recent Studies (post-2010) (phosphoramidic acid) |
|---|---|---|---|---|---|
| 16 | 7 | 13 | 536 | 0 | 195 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Almansa, C; Bartrolí, J; Belloc, J; Carceller, E; Cavalcanti, FL; Ferrando, R; García-Rafanell, J; Gómez, LA; Merlos, M; Ramis, I | 1 |
1 other study(ies) available for cimicoxib and phosphoramidic acid
| Article | Year |
|---|---|
New water-soluble sulfonylphosphoramidic acid derivatives of the COX-2 selective inhibitor cimicoxib. A novel approach to sulfonamide prodrugs.
Topics: Acute Disease; Amides; Animals; Carrageenan; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Dogs; Edema; Half-Life; Humans; Hyperalgesia; Imidazoles; Isoenzymes; Male; Membrane Proteins; Pain Measurement; Phosphoric Acids; Prodrugs; Prostaglandin-Endoperoxide Synthases; Rats; Rats, Wistar; Solubility; Structure-Activity Relationship; Sulfonamides; Water | 2004 |